Pulmonary Associates

Phoenix, Arizona 85032

0 studies enrolling now · 29 studies all time

What they study most

Bronchiectasis, COPD, Chronic Obstructive Pulmonary Disease, Excessive Daytime Sleepiness, Healthy, Healthy Subjects, Healthy Volunteer, Healthy Volunteers, Homogeneous Emphysema, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Narcolepsy

Studies at this site

• Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection — Completed
• Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age — Completed
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• A Registry for Patients Taking Uptravi — Completed
• A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers. — Completed
• Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis — Completed
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis — Completed
• A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness — Completed
• A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy — Completed
• Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers — Completed
• Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program — Completed
• Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults — Completed
• Plasma and Intrapulmonary Concentrations Study of WCK 5222 — Completed
• Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects — Completed
• Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease — Status unconfirmed
• Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers — Completed
• A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease — Completed
• Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
• Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
• (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF — Stopped early
• Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) — Stopped early
• Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome — Completed
• The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting — Stopped early
• Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study — Completed
• Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study — Completed
• US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study — Completed
• Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea — Completed